1. Homepage
  2. Equities
  3. Germany
  4. HANSEATISCHE WERTPAPIERBOERSE HAMBURG
  5. Sangui Biotech International, Inc.
  6. Summary
    SBH   US80105B1017

SANGUI BIOTECH INTERNATIONAL, INC.

(SBH)
 SummaryQuotesChartsNewsCalendarCompanyFinancials 
Quotes 5-day view   End-of-day quote. End-of-day quote Hanseatische Wertpapierbo…
01/12/2022 01/13/2022 01/14/2022 02/17/2022 02/18/2022 Date
0.016 0.016 0.016 0.013 0.013 Last
7625 7625 7625 18000 18000 Volume
0.00% 0.00% 0.00% -18.75% 0.00% Change
Estimated financial data (e) (USD)
Sales 2020 0,03 M - -
Net income 2020 -0,19 M - -
Net Debt 2020 0,68 M - -
P/E ratio 2020 -14,7x
Yield 2020 -
Sales 2021 0,07 M - -
Net income 2021 -0,20 M - -
Net Debt 2021 0,79 M - -
P/E ratio 2021 -21,6x
Yield 2021 -
Capitalization 3,09 M 2,93 M -
EV / Sales 2020 134x
EV / Sales 2021 90,6x
Nbr of Employees -
Free-Float 77,7%
More Financials
Company
Sangui Biotech International, Inc. focuses on the development of pharmaceutical, medical and cosmetic products. The Company develops its products through its German subsidiary, SanguiBioTech AG (Sangui GmbH). It is engaged in seeking to market and selling its products through partnerships with industry partners across the world. It focuses on the development of oxygen carriers capable of providing oxygen transport... 
More about the company
All news about SANGUI BIOTECH INTERNATIONAL, INC.
05/17SANGUI BIOTECH INTERNATIONAL INC. : - Increase in sales in the first nine months of the ye..
EQ
05/16SANGUI BIOTECH INTERNATIONAL INC Management's Discussion and Analysis of Financial Con..
AQ
05/16Sangui Biotech International, Inc. Reports Earnings Results for the Third Quarter and N..
CI
02/16SANGUI BIOTECH INTERNATIONAL INC. : Significant increase in sales in the first half of the..
EQ
02/11SANGUI BIOTECH INTERNATIONAL INC Management's Discussion and Analysis of Financial Con..
AQ
02/11Sangui Biotech International, Inc. Reports Earnings Results for the Second Quarter and ..
CI
2021SANGUI BIOTECH INTERNATIONAL INC. : - Sales of USD 18,560 in first quarter - Reduction of ..
EQ
2021SANGUI BIOTECH INTERNATIONAL INC Management's Discussion and Analysis of Financial Con..
AQ
2021Sangui Biotech International, Inc. Reports Earnings Results for the First Quarter Ended..
CI
2021SANGUI BIOTECH INTERNATIONAL INC. : Granulox is awarded the prestigious Prix Galien
EQ
2021SANGUI BIOTECH INTERNATIONAL INC. : - Sales of USD 65,582 in fiscal year 2021 - Reduction ..
EQ
2021SANGUI BIOTECH INTERNATIONAL : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION..
AQ
2021Sangui Biotech International, Inc. Reports Earnings Results for the Full Year Ended Jun..
CI
2021SANGUI BIOTECH INTERNATIONAL INC. : - Granulox(R) - Follow up
EQ
2021SANGUI BIOTECH INTERNATIONAL INC. : - Significant increase in sales in the first nine mont..
EQ
More news
News in other languages on SANGUI BIOTECH INTERNATIONAL, INC.
05/17SANGUI BIOTECH INTERNATIONAL INC. : - Umsatzsteigerung von 13% in ersten drei Quartalen -..
05/17SANGUI BIOTECH INTERNATIONAL INC. : - Umsatzsteigerung von 13% in ersten drei Quartalen -..
05/16Sangui Biotech International, Inc. annonce ses résultats pour le troisième trimestre et..
02/16SANGUI BIOTECH INTERNATIONAL INC. : Deutliche Umsatzsteigerung von 33% im ersten Halbjahr..
02/16SANGUI BIOTECH INTERNATIONAL INC. : Deutliche Umsatzsteigerung von 33% im ersten Halbjahr..
More news
Chart SANGUI BIOTECH INTERNATIONAL, INC.
Duration : Period :
Sangui Biotech International, Inc. Technical Analysis Chart | SBH | US80105B1017 | MarketScreener
Income Statement Evolution
Managers and Directors
Thomas Striepe President, CEO, CFO & Director
Hubertus Schmelz Non-Executive Director
Sector and Competitors
1st jan.Capi. (M$)
SANGUI BIOTECH INTERNATIONAL, INC.-7.14%3
MODERNA, INC.-46.53%52 047
LONZA GROUP AG-28.07%42 228
IQVIA HOLDINGS INC.-26.37%38 488
SEAGEN INC.-10.44%25 121
ICON PUBLIC LIMITED COMPANY-29.73%17 232